Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02CGY
|
|||
| Former ID |
DIB007260
|
|||
| Drug Name |
Bifemelane
|
|||
| Synonyms |
Alnert; Celeport; E-0687; MCI-2016; SON-216
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Terminated | [1] | |
| Company |
Mitsubishi-Tokyo Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H23NO
|
|||
| Canonical SMILES |
CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2
|
|||
| InChI |
1S/C18H23NO/c1-19-13-7-8-14-20-18-12-6-5-11-17(18)15-16-9-3-2-4-10-16/h2-6,9-12,19H,7-8,13-15H2,1H3
|
|||
| InChIKey |
QSQQPMHPCBLLGX-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 90293-01-9
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:92338
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase. J Neurochem. 1988 Jan;50(1):243-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.